Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S1 Generic vs Capecitabine in Metastatic Breast Cancer
NCT01655992Phase 3Terminated
- Sponsor
- Fudan University
- Start
- Jan 2012
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in breast cancer, sponsored by Fudan University. Started Jan 2012; status: terminated.
02
Drugs
tegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01655992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655992.